MindMed and Forian will collaborate on drug R&D via the real-world evidence (RWE) pathway to drug development.
Cilo Cybin Pharmaceutical Ltd. is considering an initial public offering in the next 12 months after becoming the first South African company to win the right to grow, process and package cannabis products.
A Senate-passed bill to legalize possession of certain psychedelics in California cleared a procedural hurdle on Monday—but it faces another critical challenge in the Assembly next week that could decide its fate.
Cybin announces the filing of a non-provisional patent application, the company's 14th patent application.
MindMed announces joining a research consortium, the Patient-Reported Outcome Consortium, to assist in its mission to advance medical innovation.
A Republican congressman who’s voted against modest measures to loosen barriers on psychedelic research seems to be coming around on the issue following discussions with advocates—including military veterans who have utilized the substances therapeutically—and now says the treatment “sounds amazing.”